Frances Lawhead, MD
Dermatopathology · Memphis, TNNPI 1992927214
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.0% of the total across 470 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 20.3% — the pattern of someone who eats at a lot of different presentations.
Across 470 payments — averaging $18.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$1K
- Sanofi$1K
- Novartis$1K
- Sun Pharmaceutical Industries Inc.$814
- Regeneron Healthcare Solutions, Inc.$557
- plus $2K from 23 others
What the payments were for
- Food & beverage$8,36895%
- Education$4365%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 121 | $1,790 |
| Johnson & Johnson | 60 | $1,342 |
| Sanofi | 48 | $1,037 |
| Novartis | 62 | $1,017 |
| Sun Pharmaceutical Industries Inc. | 40 | $814 |
| Regeneron Healthcare Solutions, Inc. | 25 | $557 |
| LEO Pharma Inc. | 18 | $361 |
| Lilly USA, LLC | 18 | $353 |
| Pfizer | 12 | $197 |
| Incyte Corporation | 8 | $179 |
| Organogenesis Inc. | 9 | $159 |
| Arcutis Biotherapeutics, Inc. | 8 | $129 |
| E.r. Squibb & Sons, L.L.C. | 5 | $104 |
| Bristol Myers Squibb | 2 | $102 |
| Sanofi-aventis U.S. LLC | 1 | $99 |
| Galderma Laboratories, L.p. | 6 | $86 |
| Genentech USA, Inc. | 5 | $76 |
| UCB, Inc. | 4 | $70 |
| Kerecis Limited | 2 | $65 |
| Misonix Inc | 2 | $51 |
| Boehringer Ingelheim | 2 | $43 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $38 |
| Hydrofera LLC | 1 | $26 |
| Organon | 1 | $25 |
| Biofrontera Inc. | 3 | $22 |
| Botanix SB Inc | 1 | $19 |
| Dermira, Inc. | 1 | $19 |
| Blueprint Medicines Corporation | 1 | $15 |
| Mayne Pharma Commercial LLC | 1 | $12 |
How this compares
$8,805 in reported general payments places this provider in the 85th percentile of 20 dermatopathology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 22 | $87,561 |
| Clobetasol Propionate | 60 | $2,564 |
| Triamcinolone Acetonide | 162 | $2,070 |
| Doxycycline Hyclate | 88 | $1,056 |
| Metronidazole | 22 | $1,012 |
| Dutasteride | 57 | $949 |
| Ketoconazole | 52 | $740 |
| Clindamycin Phosphate | 27 | $577 |
| ValacyclovirValacyclovir Hcl | 38 | $513 |
| Mupirocin | 53 | $511 |
| Minoxidil | 57 | $362 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 17 | $94 |
| Terbinafine Hcl | 11 | $33 |
Paid to pharmacies, not to this prescriber.
Other dermatopathology in Memphis
- John HuberMemphis$11K
- Frances BeardMemphis$9K
- Dallas ProvenceMemphis$8K
- Robin Friedman-MusicanteMemphis$6K
- Joya SahuMemphis$386
- Barry WhiteMemphis$267
- Tejesh PatelMemphis$190
- Milton RandallMemphis$69
- Lee AllenMemphis$23
- Kandice BaileyNashville$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.